79 related articles for article (PubMed ID: 14565298)
1. Dinucleoside polyphosphate NAD analogs as potential NMN adenylyltransferase inhibitors. Synthesis and biological evaluation.
Franchetti P; Cappellacci L; Pasqualini M; Grifantini M; Lorenzi T; Raffaelli N; Magni G
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):865-8. PubMed ID: 14565298
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of NAD analogs as human pyridine nucleotide adenylyltransferase inhibitors.
Franchetti P; Petrelli R; Cappellacci L; Pasqualini M; Vita P; Sorci L; Mazzola F; Raffaelli N; Magni G
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):477-9. PubMed ID: 16247974
[TBL] [Abstract][Full Text] [Related]
3. NMN/NaMN adenylyltransferase (NMNAT) and NAD kinase (NADK) inhibitors: chemistry and potential therapeutic applications.
Petrelli R; Felczak K; Cappellacci L
Curr Med Chem; 2011; 18(13):1973-92. PubMed ID: 21517775
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide mononucleotide adenylyltransferase activity in human erythrocytes.
Sestini S; Ricci C; Micheli V; Pompucci G
Arch Biochem Biophys; 1993 Apr; 302(1):206-11. PubMed ID: 8470897
[TBL] [Abstract][Full Text] [Related]
5. NAD-analogues as potential anticancer agents: conformational restrictions as basis for selectivity.
Pankiewicz KW; Zatorski A; Watanabe KA
Acta Biochim Pol; 1996; 43(1):183-93. PubMed ID: 8790723
[TBL] [Abstract][Full Text] [Related]
6. Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis.
Sorci L; Cimadamore F; Scotti S; Petrelli R; Cappellacci L; Franchetti P; Orsomando G; Magni G
Biochemistry; 2007 Apr; 46(16):4912-22. PubMed ID: 17402747
[TBL] [Abstract][Full Text] [Related]
7. Rat liver mitochondria can synthesize nicotinamide adenine dinucleotide from nicotinamide mononucleotide and ATP via a putative matrix nicotinamide mononucleotide adenylyltransferase.
Barile M; Passarella S; Danese G; Quagliariello E
Biochem Mol Biol Int; 1996 Feb; 38(2):297-306. PubMed ID: 8850525
[TBL] [Abstract][Full Text] [Related]
8. Chemoenzymatic Preparation of 4'-Thioribose NAD
Zhang XN; Dai Z; Cheng Q; Zhang Y
Curr Protoc Nucleic Acid Chem; 2019 Jun; 77(1):e83. PubMed ID: 30951610
[TBL] [Abstract][Full Text] [Related]
9. Probing Aplysia californica adenosine 5'-diphosphate ribosyl cyclase for substrate binding requirements: design of potent inhibitors.
Migaud ME; Pederick RL; Bailey VC; Potter BV
Biochemistry; 1999 Jul; 38(28):9105-14. PubMed ID: 10413485
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and SAR studies of NAD analogues as potent inhibitors towards CD38 NADase.
Wang S; Zhu W; Wang X; Li J; Zhang K; Zhang L; Zhao YJ; Lee HC; Zhang L
Molecules; 2014 Sep; 19(10):15754-67. PubMed ID: 25268725
[TBL] [Abstract][Full Text] [Related]
11. Efficient synthesis of benzamide riboside, a potential anticancer agent.
Bonnac LF; Gao GY; Chen L; Patterson SE; Jayaram HN; Pankiewicz KW
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1249-53. PubMed ID: 18066762
[TBL] [Abstract][Full Text] [Related]
12. NMNAT expression and its relation to NAD metabolism.
Jayaram HN; Kusumanchi P; Yalowitz JA
Curr Med Chem; 2011; 18(13):1962-72. PubMed ID: 21517776
[TBL] [Abstract][Full Text] [Related]
13. Targeting NAD biosynthesis in bacterial pathogens: Structure-based development of inhibitors of nicotinate mononucleotide adenylyltransferase NadD.
Sorci L; Pan Y; Eyobo Y; Rodionova I; Huang N; Kurnasov O; Zhong S; MacKerell AD; Zhang H; Osterman AL
Chem Biol; 2009 Aug; 16(8):849-61. PubMed ID: 19716475
[TBL] [Abstract][Full Text] [Related]
14. The antitumor drug, 1,3-bis(2-chloroethyl)-1-nitroso-urea, inactivates human nicotinamide mononucleotide adenylyltransferase.
Emanuelli M; Raffaelli N; Amici A; Balducci E; Natalini P; Ruggieri S; Magni G
Biochem Pharmacol; 1995 Feb; 49(4):575-9. PubMed ID: 7872964
[TBL] [Abstract][Full Text] [Related]
15. [Metabolism of NAD+ in the nuclei of human placenta].
Balducci E; Emanuelli M; Raffaelli N; Magni G
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1059-66. PubMed ID: 2560924
[TBL] [Abstract][Full Text] [Related]
16. [Enzymatic synthesis of beta-NAD+ selectively marked with tritium at adenine and its use for determining the activity of poly(ADP-ribose) polymerase].
Shram SI; Rybakova IG; Lazurkina TIu; Sidorov GV; Shilovskiĭ GA; Khokhlov AN; Miasoedov NF
Prikl Biokhim Mikrobiol; 1999; 35(6):638-46. PubMed ID: 10623965
[TBL] [Abstract][Full Text] [Related]
17. Studies of NAD kinase and NMN:ATP adenylyltransferase in Haemophilus influenzae.
Denicola-Seoane A; Anderson BM
J Gen Microbiol; 1990 Mar; 136(3):425-30. PubMed ID: 2167921
[TBL] [Abstract][Full Text] [Related]
18. Enzyme activities leading to NAD synthesis in human lymphocytes.
Sestini S; Jacomelli G; Pescaglini M; Micheli V; Pompucci G
Arch Biochem Biophys; 2000 Jul; 379(2):277-82. PubMed ID: 10898945
[TBL] [Abstract][Full Text] [Related]
19. Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors.
Franchetti P; Cappellacci L; Perlini P; Jayaram HN; Butler A; Schneider BP; Collart FR; Huberman E; Grifantini M
J Med Chem; 1998 May; 41(10):1702-7. PubMed ID: 9572896
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide adenine dinucleotide based therapeutics.
Chen L; Petrelli R; Felczak K; Gao G; Bonnac L; Yu JS; Bennett EM; Pankiewicz KW
Curr Med Chem; 2008; 15(7):650-70. PubMed ID: 18336280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
